All entries for: CSPC Megalith Biopharmaceutical Co. Ltd.

April 24, 2026

CSPC Megalith Biopharmaceutical Co. Ltd.

Orphan Drug Designation

treatment of small cell lung cancer

Disease Area: Rare Diseases
Scroll to Top